US EditionAdding MET Inhibitor Enhances Immune Response Against Small Cell Lung Tumors
Adding a MET inhibitor improves chemotherapy and immunotherapy effectiveness in small cell lung cancer, with half of patients showing MET gene overexpression, researchers said.
5 Articles
5 Articles
Adding MET inhibitor enhances immune response against small cell lung tumors
Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration with researchers from the CIBERONC cancer research network.
Gene inhibitor found to boost immunotherapy for most aggressive form of lung cancer
Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), according to a multicenter study led by the Hospital del Mar Research Institute, in collaboration with researchers from the CIBERONC cancer research network.
Adding an MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy treatment on small cell lung cancer, according to a multicenter study led by the Research Institute of the Hospital del Mar. The study, conducted in collaboration with researchers from the Cancer area of the Center for Network Biomedical Research (Ciberonc), has been published by the journal Cell Reports Medicine. The work demonstrates the importance of H…
Complementing the usual treatment with an inhibitor of a specific gene enhances the effect of therapy against more aggressive lung cancer. It is the conclusion of a multicenter study led by the hospital del Mar, in Barcelona, which prepares the ground for a new approach to the disease.Continue reading...
Adding a gene inhibitor to standard treatment improves prognosis and reduces mortality
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
